| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |